T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
FirstService
FSV
$6.24B
| $980M | 0.09% |
4,988,748
-187,736
| -4% | -$36.3M |
|
227
Trade Desk
TTD
$6.34B
| $980M | 0.09% |
10,691,856
+3,249,211
| +44% | +$285M |
|
228
Copart
CPRT
$26.8B
| $979M | 0.09% |
25,816,612
-3,992,140
| -13% | -$148M |
|
229
Elanco Animal Health
ELAN
$11.1B
| $978M | 0.09% |
34,465,054
-12,502,789
| -27% | -$389M |
|
230
Huntington Bancshares
HBAN
$36.1B
| $978M | 0.09% |
63,394,293
+4,713,788
| +8% | +$74.3M |
|
231
Ultragenyx Pharmaceutical
RARE
$2.65B
| $969M | 0.09% |
11,525,089
+66,043
| +0.6% | +$5.37M |
|
232
Assurant
AIZ
$13.9B
| $958M | 0.09% |
6,144,501
-60,146
| -1% | -$9.54M |
|
233
Las Vegas Sands
LVS
$29.6B
| $957M | 0.09% |
25,416,643
-199,185
| -0.8% | -$7.66M |
|
|
WRK
234
DELISTED
WestRock Company
WRK
| $938M | 0.08% |
21,144,926
-10,591,188
| -33% | -$498M |
|
235
RPM International
RPM
$14.7B
| $929M | 0.08% |
9,199,681
+293,603
| +3% | +$26.7M |
|
236
Trip.com Group
TCOM
$28.7B
| $928M | 0.08% |
37,710,052
-4,704,035
| -11% | -$133M |
|
237
Equity Lifestyle Properties
ELS
$12.4B
| $917M | 0.08% |
10,459,829
+1,193,209
| +13% | +$100M |
|
238
Cboe Global Markets
CBOE
$30.4B
| $916M | 0.08% |
7,028,195
-1,016,815
| -13% | -$131M |
|
239
Toast
TOST
$19.7B
| $914M | 0.08% |
27,533,723
+25,328,120
| +1,148% | +$1.17B |
|
240
Generac Holdings
GNRC
$13.1B
| $909M | 0.08% |
2,583,432
+271,290
| +12% | +$113M |
|
241
Warby Parker
WRBY
$3.13B
| $909M | 0.08% |
19,518,720
+1,875,607
| +11% | +$97.6M |
|
242
IDEX
IEX
$17.7B
| $896M | 0.08% |
3,790,134
-257,959
| -6% | -$58.6M |
|
243
PG&E
PCG
$38.3B
| $886M | 0.08% |
72,947,844
+35,077,589
| +93% | +$411M |
|
244
Aptiv
APTV
$10.1B
| $884M | 0.08% |
5,361,669
-5,298,910
| -50% | -$884M |
|
245
Air Products & Chemicals
APD
$67.7B
| $881M | 0.08% |
2,894,932
+1,762,976
| +156% | +$518M |
|
246
Wynn Resorts
WYNN
$10.6B
| $878M | 0.08% |
10,330,316
+1,469,515
| +17% | +$130M |
|
247
Paycom
PAYC
$9.52B
| $873M | 0.08% |
2,103,618
-126,642
| -6% | -$60M |
|
248
Descartes Systems
DSGX
$6.65B
| $872M | 0.08% |
10,542,450
-286,487
| -3% | -$23.5M |
|
249
Fidelity National Information Services
FIS
$21.6B
| $856M | 0.08% |
7,845,951
-4,470,383
| -36% | -$505M |
|
250
Travelers Companies
TRV
$77.2B
| $852M | 0.08% |
5,448,678
+1,930,313
| +55% | +$302M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.